BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24673289)

  • 21. Inflammatory bowel disease among college students.
    Gelpi AP
    West J Med; 1978 Nov; 129(5):369-73. PubMed ID: 726419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Crohn's disease and hidradenitis suppurativa: An announced crisis?].
    Cohen L; Fathallah N; Pommaret E; de Parades V; Cosnes J
    Presse Med; 2017; 46(7-8 Pt 1):777-778. PubMed ID: 28751066
    [No Abstract]   [Full Text] [Related]  

  • 23. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient.
    Katsanos KH; Christodoulou DK; Tsianos EV
    Am J Gastroenterol; 2002 Aug; 97(8):2155-6. PubMed ID: 12190206
    [No Abstract]   [Full Text] [Related]  

  • 24. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic inflammatory bowel disease in children. An epidemiological study from eastern Denmark 1998-2000].
    Urne FU; Paerregaard A
    Ugeskr Laeger; 2002 Dec; 164(49):5810-4. PubMed ID: 12523226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
    Moschella SL
    Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
    Nos P; Argüello L; Hoyos M; Ramírez JJ; Hinojosa J; Molés JR; García A; Berenguer M; Berenguer J
    Rev Esp Enferm Dig; 1996 Jul; 88(7):470-4. PubMed ID: 8924324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI features of hidradenitis suppurativa and review of the literature.
    Kelly AM; Cronin P
    AJR Am J Roentgenol; 2005 Nov; 185(5):1201-4. PubMed ID: 16247134
    [No Abstract]   [Full Text] [Related]  

  • 30. Hidradenitis Suppurativa in Down Syndrome: A Case Series.
    Hamadah I; Haider M; Chisti M; Binamer Y
    Pediatr Dermatol; 2017 Jul; 34(4):461-464. PubMed ID: 28636122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Obesity -- no association with inflammatory bowel disease].
    Z Gastroenterol; 2013 Aug; 51(8):704. PubMed ID: 24298618
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk of venous thromboembolism with inflammatory bowel disease.
    Saleh T; Matta F; Yaekoub AY; Danescu S; Stein PD
    Clin Appl Thromb Hemost; 2011 Jun; 17(3):254-8. PubMed ID: 20211927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of inflammatory bowel disease in British 26 year olds: national longitudinal birth cohort.
    Montgomery SM; Morris DL; Thompson NP; Subhani J; Pounder RE; Wakefield AJ
    BMJ; 1998 Apr; 316(7137):1058-9. PubMed ID: 9552907
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidence and prevalence of inflammatory bowel diseases in gastroenterology primary care setting.
    Tursi A; Elisei W; Picchio M
    Eur J Intern Med; 2013 Dec; 24(8):852-6. PubMed ID: 23867759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence of hidradenitis suppurativa in Denmark].
    Jemec GB; Heidenheim M; Nielsen NH
    Ugeskr Laeger; 1998 Feb; 160(6):847-9. PubMed ID: 9469984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognizing and managing comorbidities and complications in hidradenitis suppurativa.
    Menter A
    Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S54-6. PubMed ID: 25188459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenging Ulcerative Vulvar Conditions: Hidradenitis Suppurativa, Crohn Disease, and Aphthous Ulcers.
    Stewart KMA
    Obstet Gynecol Clin North Am; 2017 Sep; 44(3):453-473. PubMed ID: 28778643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.
    Vavricka SR; Brun L; Ballabeni P; Pittet V; Prinz Vavricka BM; Zeitz J; Rogler G; Schoepfer AM
    Am J Gastroenterol; 2011 Jan; 106(1):110-9. PubMed ID: 20808297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.
    Revuz JE; Canoui-Poitrine F; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Roujeau JC; Bonnelye G; Grob JJ; Bastuji-Garin S
    J Am Acad Dermatol; 2008 Oct; 59(4):596-601. PubMed ID: 18674845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.